Methods: 738 patients (age 62.0 + 11.1, 84% women), followed a three weeks multidisciplinary program of individual and group sessions -with physiotherapy as main focus -during the period of August 2010 to September 2016 at Skogli Health-and Rehabilitation Center, Lillehammer, Norway. 3-month follow-up: N=252 and 12-month follow-up: N=118. Data from selfreported questionnaires at T1-T4 was gathered. Paired sampled T-tests and Pearson product-moment correlation coefficients was used to analyze the data obtained, using IBM SPSS Statistics v.23. Instruments:
THU0732-HPR ENHANCED MANAGEMENT OF ANKYLOSING SPONDYLITIES THROUGH GUANGDONG INTERNET HOSPITAL IN CHINA:A RANDOMIZED, CONTROLLED TRIAL
Background: Ankylosing Spondylitis (AS) is a kind of common chronic disease.Guangdong Internet Hospital is China's first officially recognized network hospital and the government encourage development of telemedicine in the country. Increasing research evidences support the efficacy of telemedicine in management of chronic diseases. However, There are still few researches about AS management by using telemedicine. Objectives: We here conducted a 6-month randomized, controlled trial to evaluate the feasibility and efficacy of Guangdong Internet Hospital in AS management. Methods: A total of 102 AS patients were randomly divided into two groups: standard care (ST) group or standard care with Network-Enhanced Management (ST-NEM) group. NEM enhanced disease management including cognition of the disease, medication monitoring, behavioral management and psychotherapy. Individuals were assessed by using several tools at baseline and 6 months later: Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for the disease acticity, Ankylosing Spondylitis Functional Index (BASFI) for the functional limitation, the Zung Self-Rating Anxiety Scale (SAS) and the Zung Self-Rating Depression Scale Zung (SDS) for the psychological status, Pittsburgh sleep quality index (PSQI) for the sleep quality, and SF-36 for the general health status. In addition, we made a satisfaction survey about the network platform in the management of the disease. Both group received the same medications during the period. There were no significant differences in baseline demographic and clinical characteristics between the two groups. Results: After 6 month, 91 patients completed the trial. 
